VALIUM
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Aug 1966
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 8h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VALIUM is an injectable small-molecule benzodiazepine approved in 1966 for acute anxiety, muscle spasms, seizure management, and procedural sedation. The drug works by enhancing GABAergic neurotransmission in the central nervous system. It remains a foundational agent in acute care and anesthesia settings.
LOE Approaching
As a mature, approaching-LOE product with moderate competitive pressure, the team is likely focused on defending market position and managing transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VALIUM offers stability in a foundational, well-understood therapeutic area with institutional adoption across hospitals and procedural settings. However, the approaching LOE and zero linked job openings signal limited expansion opportunity; career value lies in executing defensive strategies, managing generic transitions, and demonstrating institutional customer retention.
Brand Manager
Worked on VALIUM at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.